Electromed Inc. unveils investor presentation highlighting airway clearance technology and growth strategy

Reuters11-13

<a href="https://laohu8.com/S/ELMD">Electromed</a> Inc. unveils investor presentation highlighting airway clearance technology and growth strategy

Electromed Inc. has released a new investor presentation highlighting its position in the airway clearance technology market. The company reported annual revenue of $66.2 million for the twelve months ended September 30, 2025, and operates with 184 employees from its headquarters and manufacturing facility in New Prague, Minnesota. Electromed focuses on high frequency chest wall oscillation (HFCWO) therapy with its SmartVest® Airway Clearance System, which is supported by clinical outcomes data and established reimbursement codes. The presentation also outlines the company's direct-to-patient and provider model, as well as the enhanced patient experience provided by its products, including features such as a lightweight generator and intuitive user interface. TeleRespiratory services and outcomes management tools are provided to support patient adherence and physician oversight. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Electromed Inc. published the original content used to generate this news brief on November 12, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2583858350?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-13 05:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583858350","market":"nz","top_or_hot":-1,"title":"Electromed Inc. unveils investor presentation highlighting airway clearance technology and growth strategy","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ELMD\">Electromed</a> Inc. unveils investor presentation highlighting airway clearance technology and growth strategy\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Electromed Inc. has released a new investor presentation highlighting its position in the airway clearance technology market. The company reported annual revenue of $66.2 million for the twelve months ended September 30, 2025, and operates with 184 employees from its headquarters and manufacturing facility in New Prague, Minnesota. Electromed focuses on high frequency chest wall oscillation (HFCWO) therapy with its SmartVest® Airway Clearance System, which is supported by clinical outcomes data and established reimbursement codes. The presentation also outlines the company's direct-to-patient and provider model, as well as the enhanced patient experience provided by its products, including features such as a lightweight generator and intuitive user interface. TeleRespiratory services and outcomes management tools are provided to support patient adherence and physician oversight. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Electromed Inc. published the original content used to generate this news brief on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Electromed Inc. unveils investor presentation highlighting airway clearance technology and growth strategy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElectromed Inc. unveils investor presentation highlighting airway clearance technology and growth strategy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-13 05:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ELMD\">Electromed</a> Inc. unveils investor presentation highlighting airway clearance technology and growth strategy\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Electromed Inc. has released a new investor presentation highlighting its position in the airway clearance technology market. The company reported annual revenue of $66.2 million for the twelve months ended September 30, 2025, and operates with 184 employees from its headquarters and manufacturing facility in New Prague, Minnesota. Electromed focuses on high frequency chest wall oscillation (HFCWO) therapy with its SmartVest® Airway Clearance System, which is supported by clinical outcomes data and established reimbursement codes. The presentation also outlines the company's direct-to-patient and provider model, as well as the enhanced patient experience provided by its products, including features such as a lightweight generator and intuitive user interface. TeleRespiratory services and outcomes management tools are provided to support patient adherence and physician oversight. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Electromed Inc. published the original content used to generate this news brief on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDLp2jYB:1","article_id":"2583858350","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583858350","pubTimestamp":1762982365,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Electromed Inc. has released a new investor presentation highlighting its position in the airway clearance technology market. The company reported annual revenue of $66.2 million for the twelve months ended September 30, 2025, and operates with 184 employees from its headquarters and manufacturing facility in New Prague, Minnesota. Electromed focuses on high frequency chest wall oscillation  therapy with its SmartVest Airway Clearance System, which is supported by clinical outcomes data and established reimbursement codes. The presentation also outlines the company's direct-to-patient and provider model, as well as the enhanced patient experience provided by its products, including features such as a lightweight generator and intuitive user interface. TeleRespiratory services and outcomes management tools are provided to support patient adherence and physician oversight. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Techno","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","ELMD":"Electromed"},"translate_title":"Electromed Inc.发布投资者演示文稿，重点介绍气道清除技术和增长战略","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELMD":0.9},"content_text":"Electromed Inc. unveils investor presentation highlighting airway clearance technology and growth strategy\n    \n\n        Electromed Inc. has released a new investor presentation highlighting its position in the airway clearance technology market. The company reported annual revenue of $66.2 million for the twelve months ended September 30, 2025, and operates with 184 employees from its headquarters and manufacturing facility in New Prague, Minnesota. Electromed focuses on high frequency chest wall oscillation (HFCWO) therapy with its SmartVest® Airway Clearance System, which is supported by clinical outcomes data and established reimbursement codes. The presentation also outlines the company's direct-to-patient and provider model, as well as the enhanced patient experience provided by its products, including features such as a lightweight generator and intuitive user interface. TeleRespiratory services and outcomes management tools are provided to support patient adherence and physician oversight. You can access the full presentation through the link below.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Electromed Inc. published the original content used to generate this news brief on November 12, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2583858350","isCrawlerRequest":true}